(B) These medications also decrease gastrointestinal motility
Pediatric GHD Patients: Generally, a dose of 0.16 to 0.24 mg/kg body weight/week is recommended
4 This makes adequate protein intake critical
Kobashigawa JA , Katznelson S , Laks H , et al
The hospitals market will be supported by rising hospital-based diabetes management programs, increasing admissions of patients with obesity-related metabolic conditions, growing emphasis on evidence-based prescribing by endocrinology departments, expanding treatment of high-risk individuals requiring specialist supervision, rising availability of reimbursement pathways through hospital systems and growing adoption of structured chronic-care protocols involving GLP-1 therapies
Notes from the field: Kratom (mitragyna speciosa) exposures reported to poison centers united states, 20102015